Orthopediatrics Corp (KIDS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Orthopediatrics Corp (KIDS) has a cash flow conversion efficiency ratio of 0.003x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($928.00K) by net assets ($343.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see KIDS company net worth for the company's overall valuation and market capitalisation.
Orthopediatrics Corp - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Orthopediatrics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Orthopediatrics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Orthopediatrics Corp ranked by their cash flow conversion efficiency. Explore Orthopediatrics Corp (KIDS) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Indigo Paints Limited
NSE:INDIGOPNTS
|
0.027x |
|
TPI Polene Public Company Limited
BK:TPIPL
|
0.015x |
|
Northrim BanCorp Inc
NASDAQ:NRIM
|
0.115x |
|
Beijing JCZ Technology Co. Ltd. A
SHG:688291
|
N/A |
|
Canadian Banc Corp
TO:BK
|
0.022x |
|
Changhong Meiling Co Ltd
SHE:000521
|
-0.004x |
|
NETGEAR Inc
NASDAQ:NTGR
|
-0.019x |
|
Hubei Kailong Chemical Group Co Ltd
SHE:002783
|
0.000x |
Annual Cash Flow Conversion Efficiency for Orthopediatrics Corp (2014–2025)
The table below shows the annual cash flow conversion efficiency of Orthopediatrics Corp from 2014 to 2025. View Orthopediatrics Corp (KIDS) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $346.60 Million | $-4.85 Million | -0.014x | +81.65% |
| 2024-12-31 | $354.57 Million | $-27.05 Million | -0.076x | -6.34% |
| 2023-12-31 | $377.02 Million | $-27.05 Million | -0.072x | -24.79% |
| 2022-12-31 | $378.65 Million | $-21.77 Million | -0.057x | +0.83% |
| 2021-12-31 | $225.37 Million | $-13.06 Million | -0.058x | +26.56% |
| 2020-12-31 | $234.77 Million | $-18.53 Million | -0.079x | +36.76% |
| 2019-12-31 | $142.36 Million | $-17.77 Million | -0.125x | +34.53% |
| 2018-12-31 | $81.73 Million | $-15.58 Million | -0.191x | -25.47% |
| 2017-12-31 | $47.49 Million | $-7.22 Million | -0.152x | +18.61% |
| 2016-12-31 | $5.99 Million | $-1.12 Million | -0.187x | -136.81% |
| 2015-12-31 | $11.31 Million | $-892.00K | -0.079x | +85.72% |
| 2014-12-31 | $17.98 Million | $-9.92 Million | -0.552x | -- |
About Orthopediatrics Corp
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sp… Read more